elevated liver enzymes and semaglutide Wegovy Enzymes: Monitoring Safety Guidance Semaglutide 2·4 mg once weekly

The diabetes version follows a similar pattern: If manufacturing an oral version requires complex formulations, intensive dosing schedules, and strains the supply chain by demanding more API for the same therapeutic effect, why bother developing it

Administration : Oral, once daily Mechanism : Selective GLP-1 receptor agonist Efficacy : 9.414.7% weight loss at 36 weeks in Phase 2 trials Significant HbA1c reduction Safety : Mostly mild-to-moderate gastrointestinal side effects This makes Orforglipron an exciting option for patients seeking needle-free therapy with meaningful weight and glucose control benefits

doi: 10.3109/00365513.2013.773591

Could connected tools or telehealth improve patient engagement and adherence

Aim to drink 4-6 fluid ounces of water every hour between meals and snacks